At the news
? NEUTRALIMPACT 3/10 SC 13G filed Nov 13, 2026 at 16:04 ET
Spruce Street Capital LP filed a Schedule 13G disclosing a 6.4% passive stake in Yarrow Bioscience, representing 607,382 shares as of September 30, 2026. This is a new filing by Spruce Street, adding to a series of recent 13G filings by other institutional investors (Bellevue Group at 10.6%, Invus Global at 7.2%) following Yarrow's September 2026 equity offering. The passive certification and hedge fund identity suggest a routine investment, not an activist precursor.
- Spruce Street Capital LP disclosed a 6.4% passive stake in Yarrow Bioscience, representing 607,382 shares
- Stake based on 9,437,693 shares outstanding as of September 14, 2026, after the company's public offering
- Filing certifies passive intent under Rule 13d-1(b), with no intention to influence control
- This is a new 13G filing, not an amendment to a prior filing
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access